Lexicon Pharmaceuticals (LXRX) Debt Ratio (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Debt Ratio data on file, last reported at 0.18 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 45.37% year-over-year to 0.18 in Q1 2026; TTM through Mar 2026 was 0.18, a 45.37% decrease from a year earlier, with the FY2025 full-year figure at 0.29, down 13.14% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.18, down from 0.29 in the prior quarter.
• Over the last five years, Debt Ratio for LXRX reached as high as 0.43 in Q4 2023 and fell as low as 0.12 in Q3 2022.
• Historically, Debt Ratio has averaged 0.27 across 5 years, with a median of 0.27 in 2025.
• Across the five-year window, Debt Ratio jumped 208.94% in 2022 and tumbled 45.37% in 2026, its largest moves.
• Year by year, Debt Ratio stood at 0.25 in 2022, then soared by 73.47% to 0.43 in 2023, then fell by 22.51% to 0.34 in 2024, then fell by 13.14% to 0.29 in 2025, then plunged by 36.69% to 0.18 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.18 in Q1 2026, 0.29 in Q4 2025, and 0.27 in Q3 2025.